Related Experiment Videos
Reversible depression of myocardial performance in hypophosphatemia
S V Davis1, K K Olichwier, S C Chakko
1Section of Cardiology, Veterans Administration Medical Center, Salem, Virginia 24153.
The American Journal of the Medical Sciences
|March 1, 1988
Summary
Severe hypophosphatemia (low serum phosphorus) can depress myocardial function, impacting heart performance. Correction of severe hypophosphatemia improves cardiac function, while moderate levels show no significant changes.
Area of Science:
- Cardiology
- Internal Medicine
- Biochemistry
Background:
- Conflicting results exist regarding hypophosphatemia's impact on myocardial function.
- Previous studies have not consistently differentiated between severe and moderate hypophosphatemia.
- Hypophosphatemia is a condition characterized by low serum phosphorus levels.
Purpose of the Study:
- To investigate the effects of hypophosphatemia on myocardial function.
- To determine if correction of hypophosphatemia improves cardiac performance.
- To differentiate the cardiac effects of severe versus moderate hypophosphatemia.
Main Methods:
- Systolic time intervals were measured in 19 patients with hypophosphatemia (11 severe, 8 moderate) and 14 controls.
- Measurements were taken during hypophosphatemia and after its correction.
- Left ventricular performance was assessed using echocardiography and other cardiac function tests.
Main Results:
- Severe hypophosphatemia (0.9 +/- 0.15 mg/dL) was associated with depressed left ventricular performance (p < 0.001).
- Correction of severe hypophosphatemia led to significant improvement in myocardial function (p < 0.01).
- Moderate hypophosphatemia (1.4 +/- 0.11 mg/dL) did not show significant changes in cardiac performance.
Conclusions:
- Reversible myocardial depression occurs in severe hypophosphatemia.
- Moderate hypophosphatemia does not significantly impair cardiac function.
- Accurate assessment requires differentiating severity and correcting hypophosphatemia before evaluation.